FDA Leadership Changes Tune On Pediatric Priority Review Voucher Benefit

 
• By Sarah Karlin-Smith
  
older female doctor talks to young child and parent
FDA leaders have a new message on the value of the rare pediatric PRV program with the reauthorization deadline nearing. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Rare Diseases

More from Pink Sheet